Charles Schwab’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.47M Buy
346,982
+6,156
+2% +$133K ﹤0.01% 2150
2025
Q1
$7.78M Sell
340,826
-5,595
-2% -$128K ﹤0.01% 2067
2024
Q4
$8.99M Buy
346,421
+26,462
+8% +$687K ﹤0.01% 2066
2024
Q3
$8.01M Buy
319,959
+9,750
+3% +$244K ﹤0.01% 2140
2024
Q2
$6.65M Buy
310,209
+5,939
+2% +$127K ﹤0.01% 2222
2024
Q1
$5.64M Buy
304,270
+19,146
+7% +$355K ﹤0.01% 2238
2023
Q4
$4.63M Buy
285,124
+3,126
+1% +$50.8K ﹤0.01% 2342
2023
Q3
$3.89M Buy
281,998
+16,754
+6% +$231K ﹤0.01% 2362
2023
Q2
$5.86M Buy
265,244
+7,389
+3% +$163K ﹤0.01% 2174
2023
Q1
$5.61M Buy
257,855
+3,889
+2% +$84.6K ﹤0.01% 2149
2022
Q4
$4.62M Buy
253,966
+5,191
+2% +$94.5K ﹤0.01% 2251
2022
Q3
$5.66M Buy
248,775
+23,078
+10% +$525K ﹤0.01% 2150
2022
Q2
$3.12M Buy
225,697
+53,425
+31% +$738K ﹤0.01% 2394
2022
Q1
$3.92M Buy
172,272
+6,628
+4% +$151K ﹤0.01% 2386
2021
Q4
$6.17M Sell
165,644
-27,429
-14% -$1.02M ﹤0.01% 2244
2021
Q3
$8.17M Sell
193,073
-10,105
-5% -$428K ﹤0.01% 2128
2021
Q2
$9.04M Buy
203,178
+54,000
+36% +$2.4M ﹤0.01% 2056
2021
Q1
$5.37M Buy
149,178
+5,441
+4% +$196K ﹤0.01% 2265
2020
Q4
$5.73M Buy
143,737
+5,260
+4% +$210K ﹤0.01% 2148
2020
Q3
$4.01M Buy
138,477
+116,108
+519% +$3.36M ﹤0.01% 2184
2020
Q2
$366K Buy
22,369
+3,971
+22% +$65K ﹤0.01% 2957
2020
Q1
$175K Hold
18,398
﹤0.01% 3033
2019
Q4
$298K Buy
18,398
+1,402
+8% +$22.7K ﹤0.01% 2972
2019
Q3
$283K Buy
16,996
+307
+2% +$5.11K ﹤0.01% 2980
2019
Q2
$283K Buy
+16,689
New +$283K ﹤0.01% 3034